Phys · general-medicine
Urticaria and Angioedema
Also known as hives · chronic spontaneous urticaria · CSU · chronic idiopathic urticaria · chronic autoimmune urticaria · physical urticaria · dermographism · cold urticaria · angioedema · hereditary angioedema · HAE · C1 inhibitor deficiency · ACE inhibitor angioedema · bradykinin-mediated angioedema · urticarial vasculitis · omalizumab · icatibant · lanadelumab
Consultant-physician guide to urticaria and angioedema: the lesion-duration rule (transient wheals less than 24 hours equals urticaria; persistent lesions with purpura equal urticarial vasculitis), the acute-versus-chronic classification (chronic spontaneous urticaria CSU as a mast-cell autoimmune disease), the pivotal angioedema branch point (with urticaria equals histamine-mediated; without urticaria equals bradykinin-mediated — hereditary angioedema HAE, ACE inhibitor, acquired C1-INH deficiency), the four-step EAACI treatment ladder (standard-dose H1, up to 4-fold H1, omalizumab, ciclosporin), the acute and prophylactic management of HAE (C1-INH concentrate, icatibant, lanadelumab), and the absolute rules that HAE does NOT respond to adrenaline and ACE inhibitors are never rechallenged.
On this page & tools
Your progress
Saved locally on this device.
Practise this topic
Target exams
Red flags
Urticaria and Angioedema
Meet the patient
A 62-year-old man on ramipril for five years arrives in the emergency department with a swollen tongue and lips, no wheals, no itch. The team gives adrenaline, antihistamines, and hydrocortisone, and the swelling keeps climbing towards the airway. The single question that would have changed the management is the one that sorts every angioedema: is there urticaria or not?[1]
Hold that question and the rest slots into place — wheals with the swelling mean histamine and the drugs work; swelling alone means bradykinin and the drugs do not.[1]
You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Physician Medicine fellowship atlas.
References8Show ledgerHide ledger
- [1]Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria Allergy, 2022.PMID 34536239
- [2]Maurer M, Rosén K, Hsieh HJ, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria N Engl J Med, 2013.PMID 23432142
- [3]Zuraw BL Clinical practice. Hereditary angioedema N Engl J Med, 2008.PMID 18768946
- [4]Baş M, Greve J, Stelter K, et al. A randomized trial of icatibant in ACE-inhibitor-induced angioedema N Engl J Med, 2015.PMID 25629740
- [5]Sinert R, Levy P, Bernstein JA, et al. Randomized Trial of Icatibant for Angiotensin-Converting Enzyme Inhibitor-Induced Upper Airway Angioedema J Allergy Clin Immunol Pract, 2017.PMID 28552382
- [6]Cicardi M, Banerji A, Bracho F, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema N Engl J Med, 2010.PMID 20818888
- [7]Banerji A, Riedl MA, Bernstein JA, et al. Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks: A Randomized Clinical Trial JAMA, 2018.PMID 30480729
- [8]Kaplan AP Chronic Spontaneous Urticaria: Pathogenesis and Treatment Considerations Allergy Asthma Immunol Res, 2017.PMID 28913986